Interesting comment. I'm assuming you're referring specifically to the SESRP/SESARP scheme that relates exclusively to the senior executives, and not the MPRP/EPRP schemes that are open to more junior staff.
3.7m SARs were issued to senior management (KMPs) this year, with an implied aggregate grant value of $410k (split between 5 KMPs) given the SARs were valued at $0.11 at time of issue. The SARs are in the money only if MCE stock is >$0.53 in FY18, so in a case where management fails to generate shareholder value (i.e. get the stock price up), the SARs will expire worthless. But, if we put our rose-colored glasses on and say that MCE hits $1.50 by FY18 (an obviously very bullish scenario - certainly more bullish than i am), then the dilution suffered by shareholders (i.e. the real cost of the plan) will be: ($1.50 - $0.53) * 3.7m SARs / $1.50 share price, which equates to 2.4m new MCE shares being issued. Given there's currently 94m shares on issue, the SAR conversion under this scenario - where shareholders would have more than tripled their money in a 3-year period - represents a 2.5% dilution of the company's equity capital. My question to you is: would you really be that annoyed to see the 5 KMPs be issued stock representing a dilution of common stockholders by 2.5%, if that same management team had more than tripled the value of your equity in 3 years? That seems like a pretty reasonable deal to me.
In regard to 'lacking imagination' or not having a single achievement to their credit aside from devising a new executive incentive scheme, what would you suggest management to have done differently over the last few years, amidst the sharpest downturn their industry had seen in 2-3 decades (probably the sharpest downturn any of them had seen in their executive careers)? You have the benefit of hindsight, so i imagine you'll be able to come up with an extensive list - i'd be interested to hear.
- Forums
- ASX - By Stock
- Views on MCE?
MCE
matrix composites & engineering limited
Add to My Watchlist
3.64%
!
28.5¢

Interesting comment. I'm assuming you're referring specifically...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $63.78M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.0¢ | $335.1K | 1.194M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67555 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 38700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48955 | 0.275 |
1 | 42892 | 0.270 |
1 | 100001 | 0.265 |
2 | 5000 | 0.250 |
1 | 4000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 38700 | 1 |
0.290 | 74046 | 3 |
0.300 | 17097 | 2 |
0.310 | 10000 | 1 |
0.320 | 5000 | 1 |
Last trade - 15.59pm 04/07/2025 (20 minute delay) ? |
Featured News
MCE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online